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HumanT-cell lymphotropic virus type 1 (HTLV-1) has been identified as the causative agent
of adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic parapare-
sis (HAM/TSP). The virus infects between 15 and 20 million people worldwide of which
approximately 2–5% develop ATL. The past 35 years of research have yielded significant
insight into the pathogenesis of HTLV-1, including the molecular characterization ofTax, the
viral transactivator, and oncoprotein. In spite of these efforts, the mechanisms of oncogen-
esis of this pleiotropic protein remain to be fully elucidated. In this review, we illustrate the
multiple oncogenic roles of Tax by summarizing a recent body of literature that refines our
understanding of cellular transformation. A focused range of topics are discussed in this
review includingTax-mediated regulation of the viral promoter and other cellular pathways,
particularly the connection of the NF-κB pathway to both post-translational modifications
(PTMs) of Tax and subcellular localization. Specifically, recent research on polyubiquitina-
tion ofTax as it relates to the activation of the IkappaB kinase (IKK) complex is highlighted.
Regulation of the cell cycle and DNA damage responses due to Tax are also discussed,
including Tax interaction with minichromosome maintenance proteins and the role of Tax
in chromatin remodeling. The recent identification of HTLV-3 has amplified the importance
of the characterization of emerging viral pathogens. The challenge of the molecular deter-
mination of pathogenicity and malignant disease of this virus lies in the comparison of
the viral transactivators of HTLV-1, -2, and -3 in terms of transformation and immortaliza-
tion. Consequently, differences between the three proteins are currently being studied to
determine what factors are required for the differences in tumorogenesis.
Keywords: HTLV-1,Tax, NF-κB, post-translational modification
INTRODUCTION
The Human T-cell lymphotropic virus type 1 (HTLV-1) was dis-
covered in the early 1980s by two independent groups working in
the United States (Gallo lab; Poiesz et al., 1980, 1981) and Japan
(Hinuma lab; Yoshida et al., 1982). It is a complex retrovirus and a
member of theDeltaretrovirus genus. Although there are currently
four known types of HTLV, HTLV-1 is by far the most pathogenic
of the group and has the distinction of being the first oncogenic
retrovirus discovered in humans (Mahieux and Gessain, 2007). It
infects an estimated 15–20 million people worldwide and has been
implicated as the causative agent in a number of disease conditions.
Notably, among these conditions is Adult T-cell Leukemia (ATL)
and HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
(HAM/TSP). HAM/TSP was first described in 1969 over a decade
prior to the discovery of HTLV-1. It presents with inflammatory
symptoms and incomplete paralysis of the limbs (Gessain et al.,
1986; Kfoury et al., 2012). ATL was first characterized by the work
of (Takatsuki et al., 1977; Poiesz et al., 1980; Yoshida et al., 1984;
Gallo, 2011; Kfoury et al., 2012). It develops in approximately 2–
5% of all HTLV-1 infected patients and results in an aggressive
disease course that is highly resistant to current chemotherapy
treatments. The rates of HAM/TSP are less easily determined as the
disease is often misdiagnosed; however, it has been estimated that
there are approximately 3,600 unrecognized cases of HAM/TSP in
the United States alone (Orland et al., 2003; Goncalves et al., 2010;
Poetker et al., 2011).
The HTLV-1 transactivator protein, Tax, has been identified as
a protein of significant interest in HTLV-1 pathogenesis as it is
a potent activator of a variety of transcription pathways and has
been shown to be sufficient to immortalize T-cells in vitro and
thus plays an important role in cellular transformation (Yao and
Wigdahl, 2000; Grassmann et al., 2005; Kashanchi and Brady, 2005;
Mahieux and Gessain,2007). Tax is a highly promiscuous viral pro-
tein, coded by open reading frame (ORF) IV in the pX region of the
HTLV-1 genome, as seen in Figure 1 (Brady et al., 1987; Yoshida
et al., 1989; Yoshida, 1994). The protein is comprised of 353 amino
acids (40 kDa) and contains a number of interesting domains that
allow it to interact with a myriad of cellular factors thus affect-
ing a large number of cellular functions and products (Harrod
et al., 1998; Nicot et al., 1998; Chun et al., 2000; Gachon et al.,
2000; Xiao et al., 2000; Li et al., 2003; Hirata et al., 2004; Wu et al.,
2004; Kfoury et al., 2012). However, a complete mechanism for
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FIGURE 1 |The HTLV-1 viral genome highlighting theTranscriptional
Response Elements (TRE). A schematic diagram of the HTLV-1 viral genome
illustrating the interaction between the TRE-1 and the Tax/CREB/CBP/p300
complex. Transactivation of transcription at the viral LTR is a critical role of Tax
in HTLV-1 infected cells as this ultimately leads to the expression of all viral
genes. Here, major viral proteins are linked to their genomic regions and the
LTR is divided into the U3, R, and U5 regions. The U3 region is of significant
importance in Tax-mediated transcription and thus is highlighted. This region
contains three TRE-1 regions, each capable of recruitment of the
Tax/CREB/CBP/p300 complex. TRE-1 is shown to contain three domains (A, B,
and C) of which B, in conjunction with either A or C, is required for the
Tax/CREB/CBP/p300 complex to bind to the LTR.
Tax-mediated oncogenesis remains to be fully elucidated. In this
review, an important set of Tax interactions in HTLV-1 infected
cells are summarized. The potential roles of Tax in transcription
and oncogenesis are emphasized. Comparisons between the Tax
proteins of HTLV-1, -2, and -3 are also highlighted.
TAX PROMOTES TRANSCRIPTION BY TRANSACTIVATING
CELLULAR TRANSCRIPTION FACTORS
The HTLV-1 genome is capped on either end by a long terminal
repeat (LTR). Each LTR contains three regions, the unique 3′ (U3),
the repeated (R), and the unique 5′ (U5) regions (Figure 1). While
the R and U5 regions have been shown to be involved in a num-
ber of protein interactions, an interaction with Tax remains to be
fully described (Takebe et al., 1988; Seiki et al., 1990; Gartenhaus
et al., 1991; Kashanchi et al., 1993; Xu et al., 1996). The U3 region,
however, has been shown to be of importance in regard to regu-
lating proviral gene expression as it contains a region known as
the Tax responsive element I (TRE-1; Seiki et al., 1983; Yao and
Wigdahl, 2000; Jiang et al., 2009). TRE-1 is comprised of three
discontinuous 21-basepair (bp) repeats. Only one of these repeats
is required for transcription; however, mutations of the middle
repeat (TRE-1 II) have been shown to cause the most significant
reduction in transcription efficiency (Barnhart et al., 1997). Each
repeat contains three conserved domains (termed A, B, and C)
which comprise a total of 13 nucleotides out of the total 21 (Mont-
miny et al., 1986; Montminy and Bilezikjian, 1987; Montagne et al.,
1990; Yao and Wigdahl, 2000). Domain B is the most important
in terms of Tax-mediated transactivation as it contains five of the
eight bp that make up what is known as the viral cAMP response
element (vCRE) and, in conjunction with either domain A or C,
domain B is sufficient for Tax-mediated transactivation. vCRE is
the site at which Tax initiates transcription from the viral pro-
moter. This is achieved by successful binding of a protein complex
made up (at least in part) by the cAMP response element binding
protein (CREB), Tax, and the CREB-binding protein (CBP), or
p300. Below each of these proteins are discussed in their relation
to Tax-mediated transcription.
CREB IS SPECIFIC FOR vCRE ACTIVATION IN THE PRESENCE OF TAX
cAMP response element binding protein interacts directly with the
vCRE, thus making it a protein of paramount importance in Tax-
mediated transactivation of the viral promoter (Montminy et al.,
1986; Montminy and Bilezikjian, 1987; Montagne et al., 1990; Yao
and Wigdahl, 2000). CREB is recruited by Tax where it dimerizes
on the vCRE region of TRE-1 forming either a CREB homodimer
or CREB-Activating transcription factor family (ATF) protein het-
erodimer through interaction between the leucine zipper domains
of CREB/ATF. Tax forms a homodimer by linkage between its zinc
finger domains and binds to the CREB dimer (Franklin et al., 1993;
Habener et al., 1995; Yao and Wigdahl, 2000). The Tax dimer asso-
ciates with the G and C rich sequences that flank the vCRE thus
lending enhanced DNA binding specificity to the CREB dimer. The
resulting protein complex is specific to TRE-1 and is vital for effi-
cient continuous transcription at the vCRE (Wagner and Green,
1993; Anderson and Dynan, 1994; Paca-Uccaralertkun et al., 1994;
Tie et al., 1996). The ultimate binding, however, of the Tax/CREB
complex to the vCRE is accomplished through the use of three
tandem domains located on the CREB protein: a leucine zipper
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domain in the carboxyl terminus, a transactivation domain in the
amino terminus, and a basic DNA binding domain adjacent to the
leucine zipper domain (Hoeffler et al., 1988; Gonzalez et al., 1989;
Habener et al., 1995; Yao and Wigdahl, 2000). This formation of
the Tax/CREB/vCRE complex comprises a vital first step in tran-
scriptional activity at the LTR. It is important to note however,
that while the Tax/CREB/vCRE complex forms in a well charac-
terized fashion, a complete description of all associated factors still
remains to be developed.
Transducers of regulated CREB (TORC) proteins are an inter-
esting example of one of these associated host factors. TORCs
enhance the interaction of CREB with the TFII130 component
of Transcription factor II D (TFIID) thus enhancing the tran-
scriptional initiation potential of CREB (Koga et al., 2004; Siu
et al., 2006). These proteins can also interact with Tax to enhance
HTLV-1 transcription (Koga et al., 2004; Siu et al., 2006; Nyborg
et al., 2010). The work of Jiang and coworkers has proposed an
interesting potential role for TORC2 in HTLV-1 infections. Using a
Tax – GFP construct which is suppressed in vivo but upregulated ex
vivo, thus emulating latent infections, they showed that the down-
regulation of TORC2 corresponded with modeled latent infections
as compared to modeled acute infections (Jiang et al., 2009). This
observation is intriguing as it suggests that the Tax/CREB interac-
tion may play an integral role in the distinction between latent and
acute infections and thus further underscoring the critical role of
CREB in HTLV-1 infections.
CBP/p300 INTERACTS WITH TAX TO PROMOTE TRANSCRIPTION BY
CHROMATIN REMODELING
Another critical factor in HTLV-1 infections is the recruitment
of CBP/p300 to the Tax/CREB complex. CBP and p300 consti-
tute a pair of large (approximately 300 kDa) coactivator proteins
that share a high degree of homology (Kwok et al., 1996; Lau-
rance et al., 1997; Harrod et al., 2000; Chan and La Thangue, 2001;
Lu et al., 2002). They are involved in the regulation of almost all
known pathways of gene expression in multicellular organisms.
The ability of CBP/p300 to stimulate transcription is largely due
to their ability to acetylate both histone and non-histone substrates
(Zhang et al., 2008). Specifically, histone hyperacetylation has been
shown to be strongly associated with active transcription. Upon
recruitment to the viral promoter, the CBP/p300 complex pro-
motes chromatin remodeling (Kashanchi et al., 1998; Sharma and
Nyborg, 2008; Nyborg et al., 2010). This observation lends strong
support to the idea that Tax promotes such high levels of tran-
scription by promoting conformational changes in the chromatin
structure of the host cell.
Much like the interaction of CREB with Tax, the chromatin
remodeling required for Tax-mediated transactivation is not the
function of a single protein but rather the concert interactions of
many polypeptides. Of particular interest in chromatin remodel-
ing complexes is the SWI/SNF (switching-defective-sucrose non-
fermenting) complex. Through a combination of chromatography
and immunoprecipitation techniques, the work of Easley et al.
(2010) has demonstrated that Tax interaction with CBP/p300 and
SWI/SNF complexes are closely associated in HTLV-1 infected
cells. Utilizing a series of Brahma-related gene 1 (BRG1) mutants
and siRNA induced knockdown cells, it has been reported that the
SWI/SNF complex PBAF is vital for Tax activated transcription
of the integrated HTLV-1 genome. This assertion is supported by
the work of Van Duyne et al. (2011), who also demonstrated a
strong expression of Baf170 (a component of the PBAF complex)
in HTLV-1 infected cell lines where very little Baf170 was detected
in uninfected cell lines. Easley et al. further confirmed a decrease
in histone density around the LTR after one round of Tax activated
transcription. This observation correlates well with the chromatin
remodeling capabilities of the SWI/SNF complex and lends fur-
ther support to the hypothesis that Tax regulates transcription at
both the level of recruitment of chromatin remodeling complexes
and the level of recruitment of transcriptional factors. Evidence
was provided to suggest that the addition of Tax to the SWI/SNF
complex could increase the rate of chromatin remodeling of the
nucleosome thus aiding in the function of CBP/p300 (Easley et al.,
2010). Collectively, these data reveal CBP/p300 as a vital factor in
both Tax-mediated transactivation and Tax-mediated chromatin
remodeling.
CHROMATIN REMODELING IS OF VITAL IMPORTANCE TO
TAX-MEDIATED TRANSACTIVATION
Further work examining the proteins associated with Tax-
mediated transcription of the HTLV-1 LTR suggests that chap-
erone molecules such as Nucleosome assembly protein 1 (NAP1)
may be involved in Tax-mediated chromatin remodeling. NAP1
is a histone chaperone molecule that has been shown to be
involved in transcription-independent nucleosome eviction at
the HTLV-1 promoter (Sharma and Nyborg, 2008). These col-
leagues demonstrated this by assembling chromatin templates in
the absence of assembly proteins via salt deposition. The resul-
tant chromatin was shown to be indistinguishable from chromatin
formed via assembly factors; however, a subsequent DNA pull-
down assay revealed that the presence of p300 and Acetyl-CoA
were no longer sufficient for nucleosome eviction. The authors
then introduced purified NAP1, effectively rescuing nucleosome
eviction from the chromatin template (Sharma and Nyborg,
2008). This nucleosome eviction activity, however, was shown
to be dependent on the HAT-activity of CBP/p300. The eviction
process removes intact histones from the chromatin structure thus
opening the promoter for transcription. These data support the
emerging hypothesis that acetylation-dependent promoter nucle-
osome disassembly is a pre-requisite for strong transcriptional
activation.
In conjunction with this previous observation, p300 recruit-
ment to an integrated HTLV-1 promoter has been shown to
correlate with a decrease in acetylated histones (Lemasson et al.,
2006; Bogenberger and Laybourn, 2008; Nyborg et al., 2010). This
is unexpected as the function of p300 is to acetylate histones at
the site of the promoter. However, this observation coincided with
a similar reduction in histone H3 and linker histone H1 levels.
Together, these observations would suggest that there was a reduc-
tion in nucleosome density at the promoter (Lemasson et al., 2006;
Bogenberger and Laybourn, 2008; Nyborg et al., 2010). This sup-
ports the supposition that Tax induces nucleosome eviction at
the promoter, thus enabling strong transcriptional activity at the
HTLV-1 promoter. In fact, global reduction in histone levels in
HTLV-1 infected cell lines has been reported (Bogenberger and
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Laybourn, 2008; Sharma and Nyborg, 2008). Furthermore, Bogen-
berger and Laybourn (2008) reported that Tax alone is sufficient
to reduce histone transcript levels in Jurkat cells. Combined with
the reported ATP-independent chromatin remodeling capabilities
of NAP1, this observation of histone reduction in Tax express-
ing cells suggests that the presence of Tax results in a prolonged
unfolding of the chromatin structure; therefore, allowing constant
transcriptional activation. Thus, these data begin to describe a pos-
sible mechanism for the strong transcriptional activity of factors
activated by Tax.
In contrast to the HAT/chromatin unfolding activity of Tax
associated factors, work with histone deacetylase complexes
(HDACs) has demonstrated their ability to counteract the action
of HAT-activity containing factors. When overexpressed, HDACs
interact directly with Tax and bind to the HTLV-1 promoter, thus
repressing transcription by refolding chromatin fibers (Ego et al.,
2002; Lemasson et al., 2002, 2004; Lu et al., 2004; Mosley et al.,
2006). Consequently, they serve as a counterbalance to otherwise
largely unchecked Tax-mediated transcriptional activation. Thus
it is not surprising that Tax excludes HDAC activity at the LTR
(Mosley et al., 2006). This exclusion combined with the recruit-
ment of HAT-activity containing factors, such as CBP/p300, lends
even further support to the idea of Tax promoting a constant
“open” state of the chromatin structure.
Notably, the work of Hieshima et al. (2011) has recently added
musculoaponeurotic fibrosarcoma oncogene homolog, c-Maf (a
protein that can function as a transcriptional activator or repres-
sor depending on its binding) to the list of potentially significant
transcription factors in terms of inhibition of the Tax/CBP/p300
interaction. Using a series of luciferase assay based experiments,
they have reported that c-Maf inhibits Tax-dependent promoter
activation by competing with Tax for binding to the zinc finger
domain of CBP (Hieshima et al., 2011). The observations regard-
ing HDACs and c-Maf described above not only underscore the
importance of CBP/p300 in Tax-mediated transcription of the
LTR, but also provide two potential avenues of downregulating
viral transcription.
TAX PROMOTES THE TRANSCRIPTION OF CELLULAR
PROTEINS BY ACTIVATING SEVERAL CELLULAR FACTORS
Though the transactivation of the LTR is an essential role of Tax,
it is not the only role of this fascinating oncoprotein. It also acts
upon the host cell to regulate, manipulate, and exploit host cel-
lular pathways to mediate cellular transformation. Below, several
key transcriptional factors are discussed in their relation to their
interaction with Tax.
THE SERUM RESPONSE FACTOR IS ACTIVATED BY TAX
The serum response factor (SRF) is one of the major cellular pro-
teins activated by Tax. Genes such as c-fos, Erg-1,Erg-2, Fra-1, c-Jun,
and JunD all have SRF binding sites in their respective promot-
ers and Tax has been shown to activate all of these genes (Suzuki
et al., 1993; Fujii et al., 1994, 1995; Winter and Marriott, 2007).
This suggests Tax has an involvement in regulating SRF-dependent
transcription. Furthermore, Tax activation of this factor has been
linked to binding of the serum response element (SRE). As a num-
ber of growth regulatory genes are responsive to SRF signaling,
Tax may utilize this pathway to manipulate cell cycle and conse-
quently contribute to cellular transformation. Interestingly, c-fos
has been shown to be a potent cellular oncogene, further suggesting
a link between Tax manipulation of SRF-mediated transcription
and oncogenesis (Suzuki et al., 1993; Fujii et al., 1994, 1995; Winter
and Marriott, 2007).
The DNA sequence CC(A/T)6GG (termed the CArG box) when
situated next to a transcription factor family (TCF) Ets element
comprise the SRE. The SRF and TCF (members of which are
part of the Ets family of proteins) proteins bind to the SRE cre-
ating a ternary complex at the promoter. Tax has been shown
to interact with members of the TCF family, Elk-1 and SAP-
1, and thus by interacting with the TCF protein of this ternary
structure, Tax may dysregulate the SRF pathway (Suzuki et al.,
1993; Fujii et al., 1994, 1995; Winter and Marriott, 2007). More-
over, HTLV-1 has been shown to contain a CArG box of its own
(vCArG) within its own SRE (vSRE). This vSRE is located within
the TRE-2 region of the U3 region of the LTR. The work of
Winter and Marriott has demonstrated that not only does Tax
interact with SRF directly but that in the presence of Tax, the
SRF protein recognizes and binds to a more diverse group of
sequences as compared to the absence of Tax. Also, increased bind-
ing of SRF to the c-fos promoter in Tax expressing cells versus
non-Tax expressing cells is documented (Winter and Marriott,
2007). The continued characterization of the interaction between
Tax and SRF has provided further evidence of dysregulation of
cellular growth by Tax-mediated methods (further discussed in
later sections) and continues to provide mechanisms by which
Tax immortalizes cells and initiates the oncogenic progression of
cells.
TAX-MEDIATED ACTIVATION OF THE NF-κB PATHWAY IS
VITAL FOR HTLV-1 TRANSFORMATION
It is well established that Tax interacts with the host transcription
factor NF-κB, resulting in the activation of the NF-κB pathway,
which is critical for transformation, proliferation, and survival of
HTLV-1 infected cells. Due to the significance of Tax/NF-κB inter-
action on HTLV-1 disease states, NF-κB is given special focus in
this review.
NF-κB IS A FAMILY OF TRANSCRIPTION FACTORS
The NF-κB family of transcription factors variably regulates gene
expression as a response to dynamic post-translational modifi-
cations (PTMs), subcellular localization, and formation of homo
and heterodimer complexes of the family members (Ghosh et al.,
1998; Silverman and Maniatis, 2001; Karin and Lin, 2002; Ruland
and Mak, 2003; Sun and Xiao, 2003). This family of transcrip-
tion factors consists of five structurally similar DNA-binding
proteins, RelA (p65), RelB, c-Rel, p50/NF-κB1, and p52/NF-κB2
(Siebenlist et al., 1994). Closely related is the IκB family which
contains p100 and p105 (the two precursor proteins for the NF-
κB family members p50 and p52), respectively; the typical IκB
proteins, IκBα and IκBε; and the atypical IκB proteins, BCL-3,
IκBβ, IκBδ, and IκBNS (Siebenlist et al., 1994). The NF-κB proteins
tend to segregate in the cytoplasm of unstimulated cells, forming
inactive heterodimers with IκB proteins. Due to the innate dif-
ferences in activation mechanisms, two distinct NF-κB pathways
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exist, the canonical pathway, which is involved in the regulation
of inflammation and apoptosis, and the non-canonical pathway,
which regulates lymphoid organogenesis, to name a few cellu-
lar processes (Lo et al., 2006; Shembade and Harhaj, 2010). The
NF-κB canonical pathway is activated by intra- and extracellu-
lar stimuli, including the penultimate NF-κB activator, the pro-
inflammatory cytokine TNF-α, as well as cellular oxidative stress
or the presence of virions and bacterial virulence factors. These
extracellular stimuli bind to membrane-bound receptors span-
ning from the cytoplasm to the extracellular space and include
Growth Factor Receptors (GFRs), TNF-α Receptor (TNFR), IL-
1 Receptor (IL1R), Toll Like Receptors (TLRs), T-cell Receptors
(TCRs), and B-cell Receptors (BCRs). The non-canonical NF-κB
pathway is activated by a smaller subset of proteins as compared to
the canonical pathway, specifically, the TNF superfamily members
such as B-cell activating factor, CD40 ligand, CD70, and the recep-
tor activator of NF-κB (RANK) ligand. Both pathways, however,
ultimately involve the activation of the IKK (IκB kinase) com-
plex composed of two catalytic subunits, IKKα (IKK1) and IKKβ
(IKK2), and one regulatory subunit, IKKγ (NEMO). The activa-
tion of IKK, results in the phosphorylation of the inhibitory IκBs,
rendering them inactive. This inactivation event allows the com-
pletion of the pathway, resulting in nuclear translocation and gene
expression.
TAX MEDIATES THE ACTIVATION OF BOTH THE CANONICAL AND
NON-CANONICAL NF-κB PATHWAYS
The activation of the NF-κB pathway is highly regulated in nor-
mally dividing cells; however, most cancerous cells exhibit dysreg-
ulation of this pathway, often in a constitutively active state. This
activation is observed in HTLV-1 infected, transformed T-cells
as well as in ATL cells due primarily to the stimulation of both
the canonical and non-canonical pathway by Tax (Hirai et al.,
1992; Suzuki et al., 1993, 1994, 1995; Beraud et al., 1994; Lanoix
et al., 1994; Murakami et al., 1995; Petropoulos and Hiscott, 1998;
Yoshida, 2001).
Tax activates the canonical pathway through multiple inter-
actions with cellular proteins. In the cytoplasm, Tax directly
interacts with the IKK regulatory subunit IKKγ, resulting in
the phosphorylation, ubiquitination, and degradation of IκB and
subsequent phosphorylation, activation, and nuclear transloca-
tion of RelA (Chu et al., 1998, 1999; Harhaj and Sun, 1999;
Jin et al., 1999; Sun et al., 2000; Xiao and Sun, 2000; Xiao
et al., 2000; Carter et al., 2001b). The interaction of Tax with
IKKγ has been demonstrated in vitro in both HTLV-1 trans-
fected cells, as well as HTLV-1 transformed cell lines. Support-
ing this observation, a lack of Tax-mediated NF-κB activation is
seen in cells deficient in IKKγ. In the nucleus, Tax recruits and
manipulates RelA into subcellular foci, known as Tax nuclear
bodies (Tax NBs), where NF-κB transcriptional activation is at
a maximum level of activity (Semmes and Jeang, 1996; Bex
et al., 1997). The interaction between Tax and the IKK cat-
alytic subunits (α and β) remains to be elucidated; however it
is suggested that Tax can self-dimerize, bringing different IKK
components in close proximity, therefore promoting IKK com-
plex cross-phosphorylation (Tie et al., 1996; Jin and Jeang, 1997;
Xiao and Sun, 2000; Qu and Xiao, 2011). Another possibility is
that Tax recruits upstream factors, such as TGF-β (transforming
growth factor beta), MAP3K (mitogen activating protein kinase
kinase kinase), MEKK1 (MEK kinase 1), NIK (NF-κB-inducing
kinase), Tpl2, and TAK1 (TGF-β activated kinase 1) to activate
the IKK complex (Uhlik et al., 1998; Yin et al., 1998; Yu et al.,
2008). Recently, a cell-free assay system was developed by Shi-
bata et al. (2011) to analyze Tax-induced IKK activation. This
system showed that IKK could not be directly activated by Tax,
however was activated by MEKK1, and also suggested that Tax-
K63-linked polyubiquitination is necessary for Tax-induced IKK
activation (Shibata et al., 2011). Another study suggested that
Tax can bind directly to IKKγ and activate IKK independent
of the signaling pathways physiologically induced by cytokines
(Shimizu et al., 2011). Tax activates the non-canonical pathway
by directly inducing the processing of p100 to p52 through the
recruitment of a IKKγ/IKK complex containing only IKKα, which
both activates and recruits IKKα onto the p100 complex. Once
phosphorylated, p100 is ubiquitinylated and processed by the
proteasome as in the physiological process. This Tax-mediated
activation occurs in the absence of NIK. Tax has also been shown
to relocalize IKK to subcellular locations, such as the centrosome,
ER, Golgi-associated structures, the perinuclear compartment, or
lipid raft microdomains as a new locale for Tax-mediated IKK
activation.
NF-κB IS STRONGLY ACTIVATED IN HTLV-1 INFECTED CELLS
The NF-κB pathways are regulated with multiple feedback loops
and modulated by endogenous proteins, resulting in rapid, effi-
cient, and transient cellular gene expression. Like most cancers
and viral infections, HTLV-1 infection coincides with a loss of
the NF-κB pathway control mechanisms, resulting in constitu-
tive activation of the cascade in both HTLV-1 cell lines and
primary ATL cells. Interestingly, this activation does not occur
through overstimulation of the T-cell receptor (TCR) or other
cellular signaling proteins and kinases. As seen in Figure 2, Tax
directly accomplishes the activation of the pathway by binding to
p105, p50, p65, and p100 preventing binding of IκB inhibitors
and stabilizing the protein, as well as directly binding to IKK,
resulting in constant degradation of IκBα (Hirai et al., 1992;
Suzuki et al., 1993, 1994; Lacoste et al., 1994; Murakami et al.,
1995). Tax promotes the robustness of this pathway by inducing
the overexpression of NF-κB proteins, stimulatory cytokines, and
receptors as well as preventing the termination of the pathway.
Specifically, Tax has been shown to inactivate the NF-κB nega-
tive regulatory protein A20 (TNFAIP3) by blocking the assembly
of the A20 ubiquitin-editing complex through the inhibition of
TAX1BP1 phosphorylation. This prevents the ubiquitination of
critical signaling proteins, such as TRAFs, for degradation (Lee
et al., 2000; Wertz et al., 2004; Shembade et al., 2007a, 2008,
2009; Shembade and Harhaj, 2010). A20 is a member of a NF-κB
negative regulation, ubiquitin-editing complex containing other
regulatory proteins such as TAXIBP1, Itch, and RNF11 (Shembade
et al., 2008). Additionally, Tax is dependent on the E2 ubiquitin-
conjugating enzyme Ubc13 to interact with IKKγ, and resultant
Tax-mediated NF-κB activation. The overall activation of NF-κB
in HTLV-1 infected cells is persistent regardless of Tax expression
in transformed cells.
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FIGURE 2 | Dysregulation of the NF-κB canonical and non-canonical
pathways by HTLV-1Tax. A representative diagram of the
protein-protein interactions of HTLV-1 Tax with members of the NF-κB
family of transcription factors both in the cytoplasm and the nucleus of
an HTLV-1 infected cell. Dysregulation of the canonical pathway occurs
with the interaction of ubiquitinated Tax to the cytoplasmic IKK complex,
specifically binding to the IKKγ subunit. This interaction results in the
phosphorylation of IκB, as well as the ubiquitination and subsequent
degradation of IκB through the proteasome pathway. RelA is
subsequently activated and translocates into the nucleus where
sumoylated Tax recruits RelA to Tax nuclear bodies, driving Tax-mediated
NF-κB transcription. Dysregulation of the non-canonical pathway occurs
when biquitinated Tax interacts with the IKKα complex and activates the
processing of the precursor proteinp100 to p52. This promotes the
recruitment of RelB to the nucleus for activation of Tax-mediated NF-κB
transcription. Xcr, transcription.
TAX BOTH UNDERGOES AND PROMOTES
POST-TRANSLATIONAL MODIFICATION
As with most cellular proteins, virally encoded proteins utilize
PTMs to modify their enzymatic efficiency and expand their range
of functionality. Modifiers allow viruses to carry out a diverse set
of effects in the host cell with only a limited number of expressed
proteins. In HTLV-1 infected cells, the virally encoded Tax protein
is modified by numerous PTMs. Additionally, Tax acts upon host
cell proteins to alter their PTM moieties. The modifiers taken on
and generated by Tax allow it to affect numerous reactions within
the host cell that are vital to the viral life cycle and also lead to many
of the pathogenic outcomes indicative of HTLV-1 infections. Here
we examine in detail the Tax-induced PTMs of host cell proteins,
as well as review known PTMs of Tax and the mechanisms by
which they are generated.
TAX MODIFIES THE IKK COMPLEX
Several key PTMs of host cell proteins induced via interactions
with the HTLV-1 Tax protein have been elucidated. One vital regu-
latory complex that takes on numerous PTMs due to its association
with Tax is the IKK complex. It has been shown that Tax can asso-
ciate with all three subunits of the IKK, but that its interaction
with the IKKγ subunit leads to IKKβ and IKKγ phosphoryla-
tion (Chu et al., 1998; Carter et al., 2001a). The related IKKβ
phosphorylation has further been characterized to the Ser177 and
Ser181 residues within the T-loop of the protein (Carter et al.,
2001a). Moreover, after phosphorylation of IKKβ at the Ser177 and
Ser181 sites through the association of the IKK complex with Tax,
IKKβ is then mono-ubiquitinated. This subsequent ubiquitination
of IKKβ is required for biological activation of the IKK complex
(Carter et al., 2003). Furthermore, the mechanism by which IKK
phosphorylation is established has also been elucidated. Specifi-
cally, it has been demonstrated that Tax actually simultaneously
associates with IKK and the TGF-β activated kinase 1 (TAK1) and
stimulates TAK1 to phosphorylate IKK thereby leading to activa-
tion of the complex (Wu and Sun, 2007). Overall, the induced IKK
PTMs lead to persistent activation of IKK and phosphorylation of
the IKK target, IκBα, at Ser32 and Ser36, which in turn leads to
ubiquitin-proteasome degradation (Chu et al., 1998).
TAX MODIFIES A NUMBER OF HOST CELL PROTEINS
In addition to the PTMs induced by Tax on the IKK complex,
there are several other host cell proteins that are modified due to
their association with Tax. For one, Tax mediates the interaction
between phosphorylated FoxO4, a tumor suppressor, and the E3
ubiquitin ligase MDM2. This Tax-mediated recruitment of FoxO4
to MDM2 leads to polyubiquitination of FoxO4 and its protea-
somal degradation (Oteiza and Mechti, 2011). Additionally, Tax
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can recruit chromatin remodelers and thereby stimulate epige-
netic modifications at the integrated viral genome, which leads
to varied viral transcription. The coactivator-associated arginine
methyltransferase 1 (CARM1) and Tax associate together leading
to increased HTLV-1 transactivation via methylation of histone
H3 (Jeong et al., 2006). Alternately, histone methyltransferase
SUV39H1 can be tethered to the HTLV-1 LTR through an inter-
action with Tax that leads to repressed transactivation through
methylation of H3K9 (Kamoi et al., 2006). As evident with these
opposing enzymatic activities (i.e., CARM1 and SUV39H1), there
needs to be vigorous, future research to further define the function
of these Tax interacting proteins which may control LTR or cellular
gene expression.
TAX UNDERGOES UBIQUITINATION AND SUMOYLATION
Two well characterized PTMs of Tax are ubiquitination and
SUMOylation. These PTMs are used by the cellular machinery
to translocate Tax to various subcellular compartments and are
also required for the interaction of Tax with various host cell
proteins. Notably, PTMs of Tax are required for Tax-mediated
activation of the NF-κB pathway. It has been shown that Tax
is ubiquitinated through its interaction with Ubc13 (Shembade
et al., 2007b). DNA damage stimulates the monoubiquitination
of nuclear Tax at Ser280 and Ser284 which drives its subsequent
export from the nucleus (Gatza et al., 2007). Once ubiquitinated,
Tax associates with the IKK complex in the cytoplasm and drives
nuclear translocation of the RelA component of the NF-κB cas-
cade. SUMOylated Tax associates with RelA, p300, and free IKKγ
in nuclear bodies. It has been shown that both Lys280 and Lys284
are required for proper SUMOylation of Tax, while lysine residues
189, 197, 263, 280, and 284 are all targets for ubiquitination (Lam-
soul et al., 2005; Nasr et al., 2006). It has also been shown that the
SUMO-dependent ubiquitin ligase, Really Interesting New Gene
Finger Protein 4 (RNF4), binds to SUMOylated Tax next to the
Lys280/Lys284 ubiquitin and SUMO modification sites and ubiq-
uitinates the nuclear located protein. The ubiquitination of Tax by
RNF4 leads to the cellular translocation of Tax to the cytoplasm
and subsequently increases NF-κB activation while decreasing Tax
activity associated with interaction with nuclear CREB (Fryrear
et al., 2012). Ubiquitination of Tax at lysine residues 263, 280,
and 284 is also required for Tax assisted localization of IKKγ to
the Golgi (Harhaj et al., 2007). Interestingly, ubiquitination of
these three sites results in Tax interaction with the proteasome;
however, it is not degraded via the ubiquitin-labeled recruitment
to the proteasome (Chiari et al., 2004). Furthermore, the associ-
ation of Tax and IKKγ within the Golgi has been shown to be
mediated by an additional interaction with NEM-related protein
(NRP/optineurin). The generation of the Tax and NRP complex
was shown to be driven by the binding of polyubiquitinated Tax to
the ubiquitin-binding domain of NRP. Moreover, this interaction
was also shown to stabilize the ubiquitinated Tax and to increase
activation of the NF-κB pathway. Additionally, the Tax binding
protein, TAX1BP1, was also demonstrated to be necessary for the
Tax and NRP complex, therefore indicating a functional NF-κB
activating multimeric complex consisting of these three proteins
(Journo et al., 2009). Another recent report showed that bonding
through the Lys63 residue of the ubiquitin protein is necessary for
Tax-dependent activation of IKK while linear polyubiquitination
of Tax is not required for IKK activation (Shibata et al., 2011).
Acting in opposition to Tax ubiquitination, the deubiquitinase
CYLD interacts with Tax and removes ubiquitin moieties thereby
reducing the association of Tax with IKK. However, within HTLV-
transformed cells, CYLD is constitutively phosphorylated which
inhibits its deubiquitinase activity and, therefore, Tax association
with IKK is maintained (Wu et al., 2011). Another deubiquitinase,
Ubiquitin-specific peptidase 20 (USP20), was also shown to reduce
Tax ubiquitination and consequently inhibit Tax-mediated upreg-
ulation of the NF-κB pathway. Similar to CYLD, though, USP20 is
found to be down regulated in HTLV-1 transformed cells although
the mechanism of the USP20 suppression has not been elucidated
(Yasunaga et al., 2011).
TAX CAN ALSO UNDERGO ACETYLATION AND PHOSPHORYLATION
Beyond ubiquitination and SUMOylation, there are other impor-
tant PTMs that alter the functionality of Tax. One such identified
PTM is the acetylation of Tax at Lys346 by p300 in the nucleus
which boosts NF-κB dependent transcription (Lodewick et al.,
2009). Additionally, phosphorylation of Tax at varying residues
has also been shown to modify Tax function and localization.
Specifically, when Tax is phosphorylated at either residues Ser300
or Ser301 it is localized in nuclear bodies and aids in the activa-
tion of ATF/CREB and NF-κB regulated genes (Bex et al., 1999).
Moreover, the pleiotropic serine/threonine kinase CK2 has been
shown to phosphorylate Tax at three residues near its PDZ bind-
ing domain, specifically at Ser336, Ser344, and Thr351. Of these
phosphorylation sites, Thr351 was shown to be requisite for Tax-1
binding to the tumor suppressor scaffold protein hDlg but not for
transactivation (Bidoia et al., 2010).
THE LOCALIZATION OF TAX IN THE HOST CELL DETERMINES
FUNCTION
Intracellular trafficking of Tax, which is known to function in
both the nucleus and cytoplasm of HTLV-1 immortalized T-cells,
is essential for Tax-induced pleiotropic effects and HTLV-1’s ability
to successfully modulate transcription and effect transformation
(Figure 3). Major progress in the elucidation of Tax nucleo-
cytoplasmic shuttling and its associated functionalities has been
performed, though the precise regulatory mechanisms of intracel-
lular Tax distribution requires further clarification (Alefantis et al.,
2005a; Bertazzoni et al., 2011).
NUCLEAR LOCALIZATION OF TAX AND TRANSCRIPTIONAL ACTIVATION
Harboring a nuclear localization signal (NLS) at amino acids
18–52 of its N-terminus, Tax is predominantly a nuclear protein
(Smith and Greene, 1992). Nuclear Tax was initially identified as
Tax speckled structures (TSS) in HTLV-1 transformed T lympho-
cytes or cells transfected with Tax expression vectors (Semmes
and Jeang, 1996). These discrete foci were later defined as Tax
NBs (Bex et al., 1997). Embedded in the central domain of Tax is
a nuclear export sequence (NES) at amino acids 188–202, over-
lapping a region rich in leucine residues (Alefantis et al., 2003).
When fused to GFP, recombinant NES was found to direct nuclear
export via the CRM1 pathway but this effect was not observed in
HTLV-1 infected cells. This is suggestive of full-length Tax utiliz-
ing an alternative nuclear export pathway and that the availability
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FIGURE 3 | HTLV-1Tax subcellular localization. HTLV-1 Tax undergoes
extensive post-translational modifications that regulate Tax trafficking
through the cytoplasm and nucleus, binding partners, and consequently
its function. The figure shows Tax translocation from nucleus to
cytoplasm through a sumoylation/ubiquitination cycle. Cytoplasmic
ubiquitinated Tax activates several signal transduction pathways and can
be found in association with the endoplasmic reticulum (ER), Golgi
apparatus, and microtubule organizing center (MTOC). Additionally,
cytoplasmic Tax can be secreted by extracellular shuttling.
De-ubiquitinated Tax migrates to the nucleus where it is sumoylated and
acetylated, resulting in assembly to nuclear bodies. Nuclear Tax can be
involved in a number of processes, including interactions with nuclear
proteins, incorporation into nuclear bodies as foci for high transcriptional
activity, being targeted for proteasomal degradation, as well as actively
being translocated into the cytoplasm via CRM1 pathway or other
pathways that need yet to be defined (STAMBPL1). Lysine 48 and 63
ubiquitin branching is denoted as Ub-K48 and Ub-K63 respectively, while
monoubiquitination at lysines 280 or 284 is indicated as K284/K280-Ub.
of the NES and NLS may require PTMs of Tax, leading to confor-
mational change or macromolecular interactions. Separately, Tax
homodimer formation has been shown to be critical for nuclear
transport, where Tax proteins deficient in dimerization failed to
localize to the nucleus and localization was subsequently rescued
once Tax dimerization activity was restored (Jin and Jeang, 1997;
Fryrear et al., 2009). Tax dimerization was found to be dictated by
a central region encompassing amino acids 127–228, which can
be further divided into three sub-dimerization domains (DD) as
DD1 (amino acids 127–146), DD2 (amino acids 181 to 194), and
DD3 (amino acids 213–228) subdomains (Basbous et al., 2003b).
These findings are indicative of a complex interplay between pri-
mary and secondary structure, and cellular localization. Moreover,
an additional Tax domain was identified to play a role in specific
Tax sub-nuclear targeting (Fryrear et al., 2009). The TSS localiza-
tion signal (TSLS) region spanning amino acids 50–75 was shown
to be necessary and sufficient in directing Tax to the TSSs. Inter-
estingly, the TSLS is a distinct and independent regulatory domain
from the adjacent Tax NLS.
Post-translational modifications of the Tax protein provide an
additional layer of complexity in the regulation of the protein’s cel-
lular distribution, and the correct pattern of these specific PTMs
is known to influence Tax nuclear localization. Correspondingly,
it has been suggested that unmodified Tax has the ability to freely
undergo nucleo-cytoplasmic shuttling (Lamsoul et al., 2005). For
example, the interplay between ubiquitination and sumoylation
play a major role in the NF-κB stimulating activity of Tax and
partake in Tax subcellular localization (Kfoury et al., 2012). This
balance between ubiquitination and sumoylation on overlapping
C-terminal lysine residues determine the separation of Tax into
the nuclear and cytoplasmic compartments, where SUMOylated
Tax predominantly exists in the nucleus while ubiquitinated Tax
predominantly localizes in the cytoplasm (Gatza et al., 2007).
Amongst other functions induced by ubiquitination of Tax, inter-
action with the ubiquitin E3 ligase PDLIM2 has been shown to
direct K48-linked polyubiquitination of Tax which in turn, targets
the molecule to the nuclear matrix for protesomal degradation
(Yan et al., 2009). Correspondingly and in response to various
genotoxic or cellular stress, Tax monoubiquitination of lysines
at positions 280 and 284 results in its CRM1-dependent nuclear
export (Gatza et al., 2007). Similarly, attachment of SUMO-1 to
Tax regulates its localization in NBs, and polysumoylated Tax is
localized and detected only to these structures. Sumoylation is
believed to regulate retention of Tax in the nucleus (Lamsoul et al.,
Frontiers in Microbiology | Virology November 2012 | Volume 3 | Article 406 | 8
Currer et al. HTLV Tax oncogenesis
2005). Likewise, data from Françoise Bex’s group has shown that
the acetylated form of Tax can be detected in Tax expressing cells as
well as in HTLV-1 transformed T lymphocytes, an event that has
transcriptional activation repercussions. This form of modified
Tax and the acetylation effecter, p300, are detected to be localized to
the nucleus (Lodewick et al., 2009, 2011). Alternatively, phospho-
rylation of Ser 300 and 301 are critical for the Tax phosphoprotein
nuclear migration (Lodewick et al., 2011). A recent RNAi study
has identified the metalloprotease STAM-binding protein-like 1
(STAMBPL1) as a host protein regulating Tax nucleo-cytoplasmic
transport. STAMBPL1 is a de-ubiquitinating enzyme that stabi-
lizes Tax by preventing its proteasomal degradation in the nucleus
(Lavorgna and Harhaj, 2012). In addition, the enzyme is a required
factor for DNA damage-induced Tax nuclear export, exemplifying
how Tax localization is a dynamic event following DNA damage
(Gatza et al., 2007; Lavorgna and Harhaj, 2012). An additional
step for Tax re-localization into the nucleus involves interac-
tions with nucleoporin proteins within the nuclear pore complex
(NPC) structures (Tsuji et al., 2007). Specifically, interaction of
the Tax N-terminal zinc finger domain with p62 nucleoporin was
observed and this import event occurs in an energy- and carrier
protein-independent manner.
CYTOPLASMIC LOCALIZATION OF TAX AND MANIPULATION OF HOST
CELLULAR PATHWAYS
As previously discussed, presence of Tax in the cytoplasm and
in the nucleus may be required for the activation of Tax-
mediated gene expression (Bex and Gaynor,1998). Overexpression
of Tax results in a heterogeneous intracellular Tax distribution
that can be diffused, punctuated, or localized in distinct Golgi
apparatus-associated lipid raft microdomain structures in the
cytoplasm (Lamsoul et al., 2005; Huang et al., 2009; Avesani et al.,
2010; Lodewick et al., 2011). The microtubule organizing center
(MTOC), in association with the cis-Golgi, has been described
as an exclusive extranuclear Tax localization site, in conjunction
with the cell–cell contact region that organizes the viral synapse
between an infected and uninfected target cell (Nejmeddine et al.,
2005). Additionally, Tax has been detected in association with
TAB2-containing cytoplasmic foci (Lamsoul et al., 2005; Alefantis
et al., 2007; Avesani et al., 2010) and with the centrosome structure
(Kfoury et al., 2008).
As indicated previously, the PTM status of Tax has a sig-
nificant outcome on its functionality and localization. To fur-
ther illustrate this point, SUMOylation and ubiquitination com-
pete for the same overlapping lysine residues that result in
opposing regulatory effects. For example, colocalized Tax and
ubiquitin molecules have been detected exclusively in the cyto-
plasm with subsequent poorly ubiquitinated Tax detection in
the nucleus possibly due to rapid proteosomal degradation or
cytoplasmic shuttling (Lamsoul et al., 2005; Gatza et al., 2007).
It is believed that ubiquitination controls Tax retention in the
cytoplasm (Lamsoul et al., 2005). Other PTM dynamics asso-
ciated with cytoplasmic Tax include Tax phosphorylation as a
pre-requisite for cytoplasmic ubiquitination of the protein, in
addition to acetylation and sumoylation (Lodewick et al., 2009,
2011). Similar to Tax nuclear import conditions, Tax export
into the cytoplasm has been shown to be carrier independent
(Tsuji et al., 2007). A recent study has described the interac-
tion between Tax and host histone methyltransferase SMYD3,
where SMYD3 contributes to preferential Tax presence in the cyto-
plasm (Yamamoto et al., 2011). Likewise, a new study has identi-
fied RNF4-mediated Tax nuclear-to-cytoplasmic enrichment that
results in increased NF-κB and decreased CREB-mediated Tax
activity (Fryrear et al., 2012). Selective depletion of RNF4 was
shown to inhibit nuclear-cytoplasmic shuttling of Tax typically
induced by DNA damage.
EXTRACELLULAR TAX CONTRIBUTES TO NEUROPATHOGENESIS OF
HTLV-1
Far less is known about Tax oncoprotein secretion by HTLV-
1 infected cells. Extracellular Tax has been coupled to ATL and
HAM/TSP symptoms. In patients with diagnosed HAM/TSP, Tax
has been shown to hyperstimulate the immune system and anti-
bodies against Tax have been shown to cross-react with neuronal
protein heterogeneous nuclear ribonuclear protein-A1 (Kubota
et al., 2000; Levin et al., 2002a,b). More specifically, extracellu-
lar Tax studies have investigated the ability of HTLV-1 to cause
demyelination and inflammation of cells from the central nervous
system (CNS; Alefantis et al., 2005b). Studies have demonstrated
cytokine release by microglial cells, in response to extracellular Tax
treatment, express TNF-α, interleukin-6 (IL-6), and interleukin-
1β (IL-1β; Dhib-Jalbut et al., 1994). In a parallel study, neuronal
cells showed a similar response mechanism via the release of TNF-
α (Cowan et al., 1997). HTLV-1 cytokine induction is known to be
dose dependent, Tax specific, and lasting up to 8 h after stimula-
tion (Dhib-Jalbut et al., 1994). Collectively, all these cytokines have
been shown to induce oligodendrocyte dysfunction which in turn
leads to neuron demyelination and other pathologies observed in
HAM/TSP patients (Alefantis et al., 2005b).
HTLV-1 is also known to infect T-cells in vivo, and even though
it can infect microglia and astrocytes in vitro, infected T-cells are
the common sources of extracellular Tax as they infiltrate the CNS
during neurological disease (Szymocha et al., 2000a,b,c). More
recently, Tax has been shown to be colocalized with cytoplas-
mic organelles that are involved in the exocytotic pathway such
as the Golgi complex and the endoplasmic reticulum (ER; Ale-
fantis et al., 2005b). Additionally, time lapse video microscopy
established cytoplasmic Tax movement in a manner coupled to
microtubule-associated protein migration or that of secretory vesi-
cles. Full-length Tax protein presence was confirmed in the culture
medium of the Tax-transduced cells.
TAX DYSREGULATES CELL CYCLE PROGRESSION
Tax has been implicated as one of the lead HTLV-1 proteins that
control cell cycle. The interaction of Tax with cell cycle com-
ponents often results in dysregulation of the normal cell cycle
controls leading to a number of cellular abnormalities including
aneuploidy and immortalization of T-cells, all of which play key
roles in oncogenesis.
TAX DISRUPTS CELL CYCLE BY INACTIVATING CHECK POINT PROTEINS
By disrupting cell cycle check points, Tax prevents programmed
cell death and promotes the proliferation of infected cells. This
has obvious advantages in terms of viral proliferation and Tax
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carries out this function in a number of ways. Specifically, Tax is
able to disrupt the G1/S transition which may be largely due to
direct interaction of Tax with cyclin dependent kinase (Cdk) 4
and Cdk6 via its amino terminal domain (Neuveut et al., 1998;
Schmitt et al., 1998; Haller et al., 2002; Yang et al., 2011). This
causes Cdk proteins to interact with Cyclin D and, subsequently,
to phosphorylate Retinoblastoma protein (Rb) in the Rb/E2F com-
plex. This inactivates Rb and releases E2F, a protein involved in the
regulation of the G1/S transition. Alternately, Tax can induce pro-
teasomal degradation of Rb (Kehn et al., 2005). Tax also binds
directly to Chk1 and Chk2 proteins leading to their inactiva-
tion (Haoudi et al., 2003; Park et al., 2004, 2006; Datta et al.,
2007). This results in an unchecked interaction between Cdc25
and Cyclin B/Cdk1. Cyclin B/Cdk1 is responsible for regulating
the G2/M checkpoint which, when it is stimulated by Cdc25, sig-
nals the cell to move forward into mitosis. Through interactions
with other cellular proteins, Tax effectively modulates the rate of
transition between various stages of the cell cycle. For example,
Tax influences E2F and Cyclin B/Cdk1 to deregulate S phase and
mitosis transitions in an accelerated manner. This increased rate
of replication could result in errors throughout the cell cycle and
thus promote cellular transformation. Moreover, Tax transacti-
vates the transcription of proteins which promote cell growth
such as Cyclin D2, Cdk4, and Cdk6 (Santiago et al., 1999; Iwanaga
et al., 2008; Silbermann et al., 2008; Mizuguchi et al., 2009). Tax
localizes at the centrosome during M phase (Pumfery et al., 2006;
Afonso et al., 2007). Centrosomes operate as the MTOC of the
cell in that they modulate the cells microtubule network. This
network is critical for functions such as chromosome segrega-
tion, cell division, cellular development, and intracellular support
(Pumfery et al., 2006; Afonso et al., 2007). Tax localization at
this site during M phase suggests a key role for Tax to play in
aneuploidy.
There appear to be three general types of errors that can occur
leading to aneuploidy: (i) increased centrosome duplication; (ii)
failure to complete cytokinesis; and (iii) incomplete or improper
splitting during mitosis (Pumfery et al., 2006). Tax associates with
hsMAD1, a mitotic spindle checkpoint (MSC) protein, causing
MAD1 and MAD2 to translocate to the cytoplasm. By interfering
with the localization of these two proteins, Tax effectively dis-
rupts normal signaling in the event of a chromosomal segregation
error. This allows M phase to proceed uninterrupted leading to
aneuploidy (Jin et al., 1998; Pumfery et al., 2006).
A centrosomal protein known as Tax1BP2 has been impli-
cated in Tax related aneuploidy. Studies have shown that cells
with increased amounts of Tax1BP2 show a significantly lower
tendency to contain supernumerary chromosomes and cells with
diminished quantities of Tax1BP2 have a greater tendency toward
aneuploidy (Ching et al., 2006; Pumfery et al., 2006). Furthermore,
Tax interacts directly with Tax1BP2 and Tax mutants that fail to
interact with Tax1BP2 show a decrease in aneuploidy (Ching et al.,
2006; Pumfery et al., 2006). Collectively, these results indicate that
Tax and Tax1BP2 perform opposite functions in HTLV-1 infected
cells (Afonso et al., 2007). All together these observations provide
evidence of a direct link between Tax expression and cell cycle
abnormalities leading to cellular transformation.
TAX DIRECTLY REGULATES INTERLEUKIN EXPRESSION AND
PROMOTES CELLULAR PROLIFERATION AND IMMUNE MODULATION
Studies of HTLV-1 have demonstrated the ability of the virus to
promote the expression of cytokines and their receptors, such
as T-cell growth factor interleukin-2 (IL-2) and the subunit IL-
2 receptor α chain (IL-2Rα) of its receptor complex (Ballard
et al., 1988; Ruben et al., 1988; Hoyos et al., 1989; McGuire et al.,
1993; Good et al., 1996; Grassmann et al., 2005). The increased
expression of these proteins leads to increased proliferation of
infected cells. Furthermore, a number of other interleukins exhibit
increased expression in cells infected with HTLV-1. Among them,
IL-21 and its receptor subunit IL-21R stand out as IL-21 activates
a number of intracellular pathways required for proliferation in
T-cells. The recent work of Mizuguchi et al. has indicated that Tax
specifically plays a role in the upregulation of IL-21 and IL-21R.
In fact, these colleagues indicate not only an increase in IL-21 and
IL-21R mRNA expression in the presence of Tax, but also that the
promoters for each contain Tax responsive elements. It is impor-
tant to note, however, that these experiments were conducted in
Jurkat cells transfected with Tax and the induction of IL-21 by Tax
has not yet been validated in an infected cell line (Mizuguchi et al.,
2009).
In addition to IL-21, an upregulation of IL-13 and its receptor
α1 is observed in HTLV-1 infected patients due to stimulation of
the IL-13 promoter by Tax (Silbermann et al., 2008). IL-13 exhibits
a number of immune modulating functions including inhibition
of tumor immuno-surveillance. By overexpressing IL-13, HTLV-1
infected cells can overcome some of the host’s antiviral responses
(Silbermann et al., 2008). Furthermore, Tax-mediated stimulation
of the nuclear factor of activated T-cells (NFAT) pathway has been
shown to be sufficient in order to induce IL-13; however, inhi-
bition of the NFAT pathway did not abolish IL-13 upregulation.
In fact, the work of Silbermann and colleagues shows that IL-13
can also be upregulated via Tax-mediated activation of the NF-
κB pathway. This adds IL-13 to an increasing list of interleukins
that are susceptible to upregulation via Tax-mediated stimula-
tion (Niinuma et al., 2005; Silbermann et al., 2008; Mizuguchi
et al., 2009). This collective observation could begin to explain the
ubiquitous upregulation of interleukins in Tax expressing cells.
The characterization of other interleukins that are regulated by
Tax raises an interesting point for consideration. Mizuguchi and
coworkers propose that the proliferation of HTLV-1 infected cells
may be in response to several cytokines and not limited to IL-
2. This would provide a possible explanation for the shift from
IL-2-dependent to IL-2-independent growth patterns observed in
infected cells as a combination of other Tax regulated cytokines
could prove to be a stronger regulator of cellular growth than IL-2
alone. This avenue of thought will require further investigation
to fully elucidate interleukin involvement in HTLV-1 infected cell
growth. In the meantime, however, IL-2 remains a cytokine of
significant interest.
One of the hallmarks of cellular transformation in HTLV-1
infected cells is the change from an IL-2-dependent to an IL-2-
independent growth pattern. The recent work of Yoshita et al.
(2012) has demonstrated that by activating the mTOR kinase, Tax
can stimulate the mouse T-cell line, CTLL-2, to transfer from an
Frontiers in Microbiology | Virology November 2012 | Volume 3 | Article 406 | 10
Currer et al. HTLV Tax oncogenesis
IL-2-dependent growth to an IL-2-independent growth. This pro-
vides new evidence to the debate over how HTLV-1 transformed
cells begin as IL-2-dependent and later become IL-2-independent.
This debate has brought into question the oncogenic properties
of Tax. For example, the work of Bellon et al. suggests that the
oncogenic properties of Tax have been largely misunderstood. The
authors observed that much of the experiments pertaining to Tax-
mediated oncogenesis were carried out in established cell lines.
They argued that cell lines contain their own idiosyncrasies and
thus were not truly indicative of the cellular transformation that
occurs in infected patients. Therefore, the authors performed a
number of experiments in order to compare the effects of Tax
on established cell lines as opposed to primary cells. Their results
suggest that immortalization of primary cells by Tax alone is rare
and that the expression of Tax is not sufficient to induce the cells
to transition from IL-2-dependent growth to IL-2-independent
growth (Bellon et al., 2010). This debate is ongoing and has led to
postulations that Tax is important for the initiation of transforma-
tion thus suggesting another factor, for example microRNA, being
responsible for chronic transformation (Jeang, 2010). Clearly, the
full oncogenic properties of Tax remain to be elucidated.
Finally, the HTLV-1 basic leucine zipper factor (HBZ) has
recently become a protein of interest in the HTLV-1 oncogenesis
story. HBZ, an antisense viral protein, was originally identified as
associated with CREB-2 (an antisense transcription factor similar
to CREB) which inhibited viral transcription at the 5′ LTR (Gau-
dray et al., 2002). The work of Lemasson et al. (2007) demonstrated
that HBZ could also interact with CREB and CBP/p300. This inter-
action effectively abolished binding to the TRE-1 as well as the
CRE, thus silencing Tax-mediated transcription (Gaudray et al.,
2002; Clerc et al., 2008). This transcription suppressor function
is carried out by the HBZ protein; however, the HBZ mRNA has
been shown to promote T-cell proliferation by Satou et al. (2006).
Furthermore, it was shown that only spiced HBZ (as opposed to
unspliced HBZ) could induce ATL cell proliferation (Yoshida et al.,
2008). These observations combined strongly support the notion
that HBZ plays an important role in HTLV-1 oncogenesis; how-
ever, further study will be required to fully determine the role of
this interesting protein.
TAX PROMOTES CELLULAR TRANSFORMATION BY
INHIBITION OF CELLULAR DNA REPAIR MECHANISMS
While the ability of Tax to directly immortalize cells remains a
point of debate, the inhibition of cellular DNA damage repair
mechanisms has been clearly demonstrated. The involvement of
HTLV-1 Tax in DNA damage is twofold. Firstly, Tax interferes
with a multitude of cellular DNA repair mechanisms, including
base (BER) and nucleotide (NER) excision repair, human mis-
match repair (MMR), non-homologous end joining (NHEJ), and
damage response signaling via ATR/CHK1 (Jeang et al., 1990;
Philpott and Buehring, 1999; Kao et al., 2000a; Lemoine et al.,
2000; Haoudi et al., 2003; Marriott and Semmes, 2005; Edwards
and Marriott, 2008; Ducu et al., 2011). In doing so, Tax effectively
aids in perpetuating an environment that promotes the replica-
tion and maintenance of genomic lesions. HTLV-1 Tax impairs
BER by targeting DNA polymerase β; the transrepression of DNA
polymerase β promoter by Tax reduces the amount of enzyme
available for repair of single stranded lesions of six nucleotides or
less.
Though the NER functions to repair bulky mutations within
DNA caused by UV damage and carcinogens, Tax suppresses this
mechanism by targeting both the tumor suppressor p53 and pro-
liferating cell nuclear antigen (PCNA). Interestingly, Schavinsky-
Khrapunsky et al. (2008) report a phenomenon whereby low
cellular Tax levels enhance NER, while elevated Tax levels within
the cell impair NER. In cells expressing reduced levels of Tax,
active p53 protein is greatly augmented and capable of stimulating
NER. Though the levels of p53 mRNA and protein remain unal-
tered in cells expressing increased levels of Tax, the accumulated
p53 is functionally inactivated and incapable of stimulating NER
(Gatza et al., 2003; Schavinsky-Khrapunsky et al., 2008). Addi-
tional evidence suggests that increased levels of Tax impairs NER
via a mechanism independent of p53 (Matsuoka and Jeang, 2011).
Alternatively, the expression of Tax has been shown to transactivate
the PCNA promoter, and interfere with binding of the repres-
sor PIR (pirin, iron-binding nuclear protein) complex containing
TBP at the PCNA promoter. Thus, the increased transcription of
PCNA could function to impair NER (Kao and Marriott, 1999;
Kao et al., 2000b; Lemoine et al., 2000). Protection against spon-
taneous and insertion/deletion mutations offered by the human
mismatch repair is diminished by the expression of Tax. In examin-
ing the expression of MMR genes of patients with ATL, Morimoto
et al. describe altered expression of genes including human MutL
homolog 1 (hMLH1), human MutS homologs 2, 3, and 6 (hMSH2,
hMSH3, and hMSH6), and human post-meiotic segregations 1
(hPMS1). They propose that the attenuated expression of hMSH2
and methylation within the hPMS1 promoter contribute to the
malfunction of the MutS and MutL repair mechanisms (Morimoto
et al., 2005).
NHEJ remains the most widely used cellular repair mecha-
nism to correct double stranded DNA breaks in G0, G1, and S
phase (Ducu et al., 2011). Tax targets the DNA-dependent kinase
(DNA-PK) complex and more specifically the catalytic subunit
(DNA-PKCS) and the kinase domain of DNA-PK, Ku, a dimer
composed of Ku70 and Ku80 subunits (Ducu et al., 2011). Durkin
et al. (2008) show that Tax colocalizes with active phosphorylated
DNA-PKCS, which are more abundant in Tax expressing cells. By
constantly activating DNA-PKCS, Tax appears to hijack and con-
stitutively activate a normal DNA repair mechanism, ultimately
impairing the ability of the cell to sense legitimate DNA dam-
age (Durkin et al., 2008). Durkin and colleagues also show that
Tax suppresses the expression of Ku80, ultimately decreasing the
amount of active Ku within the nucleus. This diminished availabil-
ity and function of Ku allows for the accumulation of unrepaired
double stranded DNA breaks within the nucleus.
Tax has also been shown to target the DNA damage sensor
ataxia telangiectasia mutated (ATM) and its target CHK2, both
necessary for initiating the signaling involved in DNA repair of
double stranded breaks (Reinhardt and Yaffe, 2009). Since ATM
and CHK2 function to control the cell cycle progression through
the G1/S checkpoint, targeting ATM and CHK2 by Tax prevents the
appropriate sensing and correcting of DNA damage and promotes
progression through this checkpoint. ATM, a serine-threonine
kinase, is stimulated by double stranded DNA breaks and becomes
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activated by phosphorylation and subsequent dissociation into
monomers (Reinhardt and Yaffe, 2009). The expression of Tax
causes dephosphorylation of ATM, which inactivates the kinase
and prevents the accumulation of ATM on chromatin surrounding
the damaged area (Van et al., 2001; Haoudi et al., 2003; Chand-
hasin et al., 2008; Chlichlia and Khazaie, 2010). The expression
of Tax resulted in a reduction of ATM-mediated phosphorylation
of the pre-existing phosphorylated H2A.X (γH2A.X) and CHK2,
preventing the accumulation of γH2A.X foci in response to DNA
damage. Thus, the recruitment of effector proteins such as MDC1
and CHK2 was impaired in the presence of Tax (Haoudi and
Semmes, 2003; Park et al., 2006; Gupta et al., 2007; Durkin et al.,
2008; Ramadan et al., 2008). This effectively blocks both scaffold
formation and the positive feedback loop involved in the repair
of double stranded breaks. Tax expression has also been shown to
interfere with other proteins involved in the ATM damage signal-
ing cascade. Firstly, Tax expression has been shown to sequester
CHK2, DNA-PK, BRCA1, and MDC1 into TSS (Fryrear et al.,
2012). By preventing ATM-mediated CHK2 phosphorylation, Tax
expression results in increased amounts of inactive CHK2. Tax
also binds directly to CHK2 and specifically inactivates the kinase
activity of this protein.
As indicated above, Tax is involved in DNA damage in two ways.
Firstly, interference by Tax with cellular response to and repair of
DNA damage allows for the propagation of genetic mutations. The
second means by which Tax contributes to DNA damage stems
from the ability of Tax to generate genomic mutations. Kinjo
et al. (2010) report that the presence of Tax in human primary
cells induces the production of reactive oxygen species (ROS),
though the mechanism for this remains incompletely understood.
They further conclude that an increase in phosphorylated H2A.X
(γH2A.X), a marker of DNA damage, resulted from the expres-
sion of Tax (Kinjo et al., 2010). Finally, the Tax protein of HTLV-1
has also been shown to induce DNA damage in a replication-
dependent manner. Boxus et al. (2012) presented data implicating
Tax expression in increasing the amount of supplementary repli-
cation origins, as well as the function of Tax in inappropriately
activating these origins via a CBP/p300 mechanism, potentially
resulting in double stranded breaks which were indicated by the
accumulation of γH2A.X foci. Interestingly, the accumulation of
γH2A.X in response to DSBs demonstrated by Boxus et al. directly
contrast the reports of Chandhasin et al. (2008) discussed above.
Thus, further research is necessary to discern the role of Tax in
generation and accumulation of γH2A.X foci.
In addition to altering the abundance and activation of repli-
cation origins, Majone and Jeang (2000) demonstrate that Tax
expressing cells exhibited increased presence of DNA fragments
containing unprotected 3′-OH ends within micronuclei, and pro-
pose that Tax suppresses a mechanism for stabilizing DNA ends.
It has also been shown that Tax expressing cells exhibit increased
frequency of micronuclei formation (Majone et al., 1993).
Currently, the role of Tax in telomere maintenance is widely
debated. Bellon et al. (2006) reported that unstimulated ATL cells
have shorter telomere lengths than uninfected cells, yet ATL cells
express increased levels of active hTERT. Upon stimulation, T-
cells expressing Tax suppressed transcription of hTERT (Zane
et al., 2011). By transcriptionally repressing hTERT, Tax expression
prevents the maintenance of telomeres, and potentially contributes
to the destabilization of DNA ends in double stranded breaks or
chromosomal fusions (Durkin et al., 2008). The findings of Gabet
et al. (2003) lend further support to the ability of Tax to suppress
hTERT activity by inhibiting hTERT transcription. Competition
between Tax and c-Myc for binding within the hTERT promoter
results in repression of hTERT. Zane et al. (2011) have reported
that Tax induces transcription of TRF1, TRF2, and POT1, which
also aid in the maintenance of shorter telomeres. Conversely, it
has been reported that Tax induces the expression of hTERT in
quiescent T-cells (Gabet et al., 2003). Here, these authors report
Tax-mediated activation of the hTERT promoter in a cell cycle
dependent manner. Interestingly, this group demonstrates Tax-
mediated repression of the hTERT promoter in growing T-cells
(Gabet et al., 2003). Thus, further research is required to fur-
ther elucidate Tax-mediated modulation of hTERT and telomere
maintenance.
The Tax oncoprotein has been implicated in chromatin dynam-
ics due to Tax-mediated repression of transcription of replication-
dependent histone genes, which could subsequently impact the
regulation of host gene expression. Bogenberger and Laybourn
(2008) propose that this Tax-mediated reduction of core and
linker histone levels could present an additional mechanism for
induction of genetic mutations. Additionally, Tax could impact
chromatin remodeling through its interaction and inactivation of
p53, a tumor suppressor that normally recruits HATs and HDACs.
By inhibiting the function of p53, Tax expression causes inap-
propriate recruitment of HATs and HDACs, subsequently altering
chromatin remodeling (Schavinsky-Khrapunsky et al., 2008).
TAX INTERACTING PROTEINS AS NOVEL THERAPEUTIC
TARGETS
Current prognosis for patients with acute ATL remains poor.
An aggressive chemotherapy regimen such as VCAP-AMP-VECP
is recommended (Tsukasaki, 2012). A combinatorial regimen of
Zidovudine/INFa is thought to have promise and introduction of
arsenic trioxide to the mix is suspected to have a more synergistic
influence in inducing Tax proteolysis (Kchour et al., 2009; Tobi-
nai, 2009; Tanosaki and Tobinai, 2010; Nasr et al., 2011; Tsukasaki,
2012; 1–5). However, as the status stands, most patients with ATL
are not curable with current chemotherapy regimens alone. Allo-
genic stem cell transplantation is recommended in many cases.
New therapeutic candidates that are undergoing clinical trials
include a defucosylated humanized anti-CC chemokine receptor 4
monoclonal antibody (Tsukasaki, 2012). Below we discuss several
novel possible therapeutic approaches as they relate to Tax.
TARGETING THE ACTIVATION OF HOST SIGNALING EVENTS IS A NOVEL
THERAPEUTIC APPROACH
Activation of the NF-κB signaling pathway, either in a Tax-
dependent or a Tax-independent manner is an important compo-
nent that contributes to cell proliferation, protection from apop-
tosis and onset of drug resistance in ATL cells (Horie, 2007; Qu
and Xiao, 2011). Inhibiting the NF-κB cascade not only induces
apoptosis in ATL cells but also reduces the number of HTLV-1
infected cells in virus carriers. Therefore, inhibition of the host
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NF-κB response to reverse these above-mentioned effects in ATL
cells has been explored as a promising therapeutic route.
BAY 11-7082, a well established inhibitor of the NF-κB cascade,
was found to induce apoptosis in both virus-infected cell lines and
primary ATL cells (Mori et al., 2002). It was also found to be
effective in preventing primary tumor growth and leukemic infil-
tration in an ATL mouse model (Dewan et al., 2003). Another
NF-κB inhibitor that has been demonstrated to have in vitro
and in vivo efficacy against ATL and HTLV-1 transformed cells
is dehydroxymethylepoxyquinomicin (DHMEQ), a derivative of
epoxyquinomicin. Treatment with DHMEQ induces apoptosis in
ATL and HTLV-1 transformed cells (Ohsugi et al., 2005, 2006;
Watanabe et al., 2005). Bortezomib, a well-documented protea-
some inhibitor has also been found to be effective in inducing
cell death in ATL cells (Satou et al., 2004). While bortezomib
can be exerting other effects as a proteasome inhibitor, it also
directly influences the NF-κB signaling cascade by preventing the
degradation of IκBαwhich results in inhibition of nuclear translo-
cation of effector subunits such as p65. This could interfere with
induction of NF-κB dependent anti-apoptotic survival mecha-
nisms, thus contributing to apoptosis of ATL cells. Additionally,
Bortezomib (PS-341) treatment was shown to cause stabilization
of IκBα as expected and down regulated expression of NF-κB -
dependent anti-apoptotic genes (Nasr et al., 2005). BMS-345541,
an NF-κB inhibitor was shown to down regulate IKKβ kinase
activity in HTLV-1 infected cells and induce apoptosis (Agbottah
et al., 2008). A p53 and NF-κB modulatory anti-cancer com-
pound 9AA was also shown to dramatically decrease survival of
HTLV-1 transformed cells (Jung et al., 2008). The authors showed
that treatment of HTLV-1 transformed cells with 9AA resulted
in an increase in p53 protein and activation of p53 transcrip-
tion activity. Additionally, the data indicated that 9AA-induced
cell death could be blocked by introduction of a p53 small inter-
fering RNA, linking p53 activity, and cell death. Therefore, the
authors suggest that normal function of p53 that would be oth-
erwise suppressed by Tax can be restored upon 9AA treatment.
With regards to NF-κB activation, the paper demonstrates that
NFkB transcriptional activity is reduced upon 9AA treatment.
Specifically, while some increase can be seen in nuclear accumu-
lation of p65, phosphorylation of p65 on Ser 536 is reduced upon
9AA treatment. Along those lines, there was decreased phospho-
rylation of IκBα suggesting that the upstream activator kinase
IKK may also be influenced by 9AA. This also correlated with
decreased DNA binding and transcription activation by p65. Cap-
saicin, a modulator of NF-κB signaling, inhibited the growth of
ATL cells mainly due to the induction of cell cycle arrest and
apoptosis. Capsaicin treatment induced the degradation of Tax
and upregulation of IκBα, therefore leading to decreased nuclear
p65 and decreased anti-apoptotic gene expression (Zhang et al.,
2003). Another interesting compound, Pyrrolidine dithiocarba-
mate (PDTC), an anti-oxidant, was also shown to induce apop-
tosis in ATL cells and HTLV-1 infected cells. It was interesting to
note that the viral protein Tax inhibited PDTC-induced apoptosis
(Arima et al., 2004). PDTC is a widely utilized dithiocarbamate
inhibitor of the NFkB signaling cascade. While the exact mech-
anism of action of PDTC in inhibition of the NFkB cascade
is currently unclear, it is suspected to either directly influence
the degradation of the IkB inhibitory subunit and/or inhibit the
cellular oxidative stress responses by means of its anti-oxidant
function (Schreck et al., 1992; Zhang et al., 2011; Ding et al.,
2012).
Although NF-κB has been heavily studied, a number of other
signaling pathways have also been investigated. Here several exam-
ples are discussed. Geranylgeranylation of Rho family GTPases
is an essential modification that is critical for multiple cellular
functions such as cytoskeletal organization, transcription and cell
cycle regulation during tumorigenesis. HTLV-1 transformed cells
were found to be sensitive to geranylgeranylation inhibitors, such
as GGTI-298, which not only decreased transcriptional activ-
ity of the viral LTR, but also decreased total Tax protein in
infected cells (Edwards et al., 2011). Inhibition of the Jak/STAT
signaling pathway by CP-690,550 was also found to be effec-
tive in vitro and in vivo against HTLV-1-induced ATL (Belrose
et al., 2011). Inhibition of Cdks by drugs such as Purvalanol A
inhibited activated viral transcription in HTLV-1 infected cells
while it did not significantly influence either basal transcrip-
tion from the HTLV-1 promoter or from promoters of cellular
genes (Wang et al., 2002; Agbottah et al., 2008). Purvalanol A
treatment also upregulated apoptosis in HTLV-1 infected cells as
evidenced by increased caspase 3 activity. The work of Agbottah
et al. (2008) has suggested that a combinatorial approach, in which
inhibitors against multiple pathways (i.e., NF-κB and Cdk) are
employed in tandem, may be more effective in combating HTLV-1
infection.
HDAC INHIBITORS MAY CONTROL THE SPREAD OF VIRAL INFECTION
As discussed above, the interplay between HDACs and Tax plays
an important role in transcription regulation. Thus, HDACs pro-
vide a potential target for therapeutic treatment. Along these lines,
Valproate (2-n-propylpentanoic acid, VPA), a histone deacety-
lase inhibitor (HDACi), triggers Tax expression, thereby expos-
ing the latent HTLV-1 reservoir to immune destruction (Belrose
et al., 2011). Additional HDACis such as MS-275, suberoylanilide
hydroxamic acid (SAHA), and LBH589 also inhibited prolifera-
tion of HTLV-1 infected and primary ATL cells (Nishioka et al.,
2008). MS-275 and SAHA treatment resulted in an alteration of
the host cell cycle proteins and induced a larger population of
HTLV-1 transformed cells to go into apoptosis. MS-275 addition-
ally influenced the NF-κB signaling cascade by down regulating
phosphorylation of IKK, decreased nuclear translocation of NF-
κB subunits and decreased promoter binding (Nishioka et al.,
2008). In the case of LBH589, it was shown that this HDACi
induced hyperacetylation of non-histone proteins such as Hsp90
in addition to histones (Hasegawa et al., 2011). This hyperacety-
lation of Hsp90 resulted in a disruption of its chaperone function
and decreased levels of phosphorylated Akt. LBH589 was shown
to induce caspase-2-mediated apoptosis in HTLV-1 transformed
cells. Additionally, LBH589 also resulted in a marked decrease in
multiple host factors involved in ATL proliferation and invasion
including CCR4 and IL-2R. Interestingly, it was also demon-
strated that LBH589 suppressed HBZ expression thus adding
weight to the more recent report on inhibition of HBZ-SI by
shRNA resulting in cell growth inhibition in ATL cells (Zhi et al.,
2011).
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HTLV-1 SHOWS A HIGH DEGREE OF SIMILARITY TO HTLV-2
AND HTLV-3
HTLV-1 was the first discovered human retrovirus in the early
1980s. Soon after its discovery HTLV-2 was described, whereas
HTLV-3 and -4 subtypes were isolated only recently (Calattini
et al., 2005; Wolfe et al., 2005). HTLV-2 is shown to be less path-
ogenic, however, it is involved in the development of HAM/TSP
(Tsubata et al., 2005). Moreover, recent studies have indicated that
co-infection with HTLV-2 may confer an immunological bene-
fit in HIV-1 infected patients, a stark contrast to HTLV-1/HIV-1
co-infections which have been shown to exhibit no effect at best
(reviewed in Beilke, 2012). Finally, HTLV-3 and -4 have not yet
been associated to any pathology, most likely because of their
recent identification, low number of identified patients and lack
of proper reagents. Furthermore, little characterization of HTLV-4
has been published; thus only HTLV-1, -2, and -3 are discussed in
this review. All four types of HTLVs, HTLV-1 to HTLV-4 contain a
transactivator protein Tax, namely Tax-1, Tax-2, Tax-3, and Tax-4.
EACH TAX EXHIBITS A SIMILAR YET UNIQUE PROTEIN STRUCTURE
The protein structure of Tax-1, Tax-2, and Tax-3 is presented in
Figure 4. Tax-1 and Tax-2 have various common domains. In the
N-terminal region of Tax-1 lies a CREB-binding region, a zinc
finger domain, and binding domains required for interaction with
proteasomal subunits, transcriptional coactivators, and proteins
involved in transcription, cell cycle progression, and in cell signal-
ing regulations. The NLS is located within the first 60 amino acid
of Tax-1, and similarly, a nuclear localization determinant (NLD)
lies in the first 42 amino acids of Tax-2 (Sheehy et al., 2006; Turci
et al., 2006). Within Tax-2 lies an additional localization domain
of about 10 amino acids at position 90–100, which has been
described to be involved in cellular localization (Meertens et al.,
2004a). Meertens et al. (2004a) found that replacing aa 90–100
sequence in Tax-1 with that of Tax-2 redirects most of the chimeric
protein into the cytoplasm as compared to predominantly in the
nucleus in the case of wild type Tax-1. The PZD binding motif on
the C-terminus of Tax-1 is absent in Tax-2. This motif allows Tax-1
to interact with many cellular factors, mostly scaffolding proteins,
such as human disk large (hDlg), human homolog Scrib (hScrib),
membrane-associated guanylate kinase-3 (MAGI-3), pro-IL16
and Erbin, all of which are unable to bind to Tax-2 (Lee et al., 1997;
Rousset et al., 1998; Suzuki et al., 1999; Wilson et al., 2003; Hirata
et al., 2004; Ohashi et al., 2004; Ress and Moelling, 2006; Arpin-
Andre and Mesnard, 2007; Okajima et al., 2008; Higuchi and Fujii,
2009). In the central region of Tax-1, Tax-2, and Tax-3 lies two
leucine zipper-like motifs at amino acids 116–145 and 213–248
(Tax-1 116RNGYMEPTLGQHLPTLSFPDPGLRPQNLYT145,
213LPTTLFQPARAPVTLTAWQNGLLPFHSTLTTPGLIW248;
Tax-2 116RNGCLEPTLGDQLPSLAFPEPGLRPQNIYT145,
213LPTTMFQPVRAPCIQTAWCTGLLPYHSILTTPGLIW248;
Tax-3 116RNNCLELTLGEQLPAMSFPDPGLRPQNIYT145,
213FPTTLFQPTRAPAVQAPWHTGLLPCQKEIATPGLIW248).
In the central region of Tax-1 lie two leucine zipper-like motifs at
amino acids 116–145 and 213–248. This region is necessary for
interacting with protein dimerization, DNA-binding domains for
proteins involved in histone methylation, cell cycle progression,
and in cell signaling transduction (Shimotohno et al., 1985;
Basbous et al., 2003a; Boxus et al., 2008; Bertazzoni et al., 2011).
There is a conserved region between Tax-1, Tax-2, and Tax-3,
putative KID-like domain [amino acids 81 to 95 (Tax-1 80QRT-
SKTLKVLTPPIT96; Tax-2 80QRTSRTLKVLTPPTT96 Tax-3
80QRTTRTLKVLTPPTT96)], which is necessary for binding to
CBP/p300 (Calattini et al., 2006). However, there are sequence
differences of Tax-3 compared to Tax-1 and Tax-2, such as a lysine
residue at 85, which is crucial for Tax-1 to bind CBP/p300 (Hira-
matsu and Yoshikura, 1986). In Tax-3 the CR2 binding region
FIGURE 4 | Structural and functional domains ofTax1,Tax2 and
Tax3. Specific domains, and the regions involved in transcriptional
activation pathways are indicated. Nuclear Localization Signal (NLS),
nuclear export signal (NES), leucin zipper region (LZR), CBP/p300
binding sequence, NF-κB binding domain as well as PDZ binding motif
are shown. Tax-2A has 331 amino acid (aa) residues, whereas Tax-2B
has a 25 aa C-terminal extension, which is depicted in Figure 4 with a
dotted square.
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(amino acids 312–319) is slightly different than that of Tax-1 and
Tax-2 (Tax-1 311YTNIPISL320; Tax-2 311YTNIPVSI320; Tax-3
311YSTVPFSL320), which has also been shown to be crucial for
the ability of Tax-1 and Tax-2 to bind to CBP/p300 (Scoggin et al.,
2001). The two amino acids belonging to the M22 domain are
also different between Tax-1, Tax-2, and Tax-3 proteins (Tax-1
130TL131; Tax-2 130SL131; Tax-3130AM131; Smith and Greene,
1990). Tax3 also contains a PDZ binding motif at its C-terminus
similar to Tax-1 (Calattini et al., 2006).
TAX-1, TAX-2, AND TAX-3 EACH INTERACT WITH A DIFFERENT SUBSET
OF CELLULAR PROTEINS
Tax-1 and Tax-2 have more than 75% homology of their amino
acid sequences, and they also have similar functions in HTLV-
infected cells, however Tax-1 may have a higher oncogenic poten-
tial compared to Tax-2 (Slamon et al., 1984; Seiki et al., 1986;
Grassmann et al., 1992; Akagi and Shimotohno, 1993; Ross et al.,
1996; Robek and Ratner, 1999; Kondo et al., 2006). Similar to Tax-
1, Tax-2 also induces the expression of a number of cellular genes
through its interaction with several transcription factors (Feuer
and Green, 2005). Tax-3, on the other hand, displays between 26
and 30% divergence at the amino acid level from Tax-1 and Tax-2,
respectively, and has been shown to be functionally more closely
related to Tax-1 than Tax-2 (Calattini et al., 2006). Despite these
differences, Tax-1 and Tax-2 both aid in transactivation of the viral
promoter though the CREB/ATF and the NF-κB pathways.
The CREB/ATF family of transcription factors play a crucial
role in the cell growth, survival, and apoptosis by modulating
CRE-directed gene transcription in response to signals such as
growth factors (Hai and Hartman, 2001; Persengiev and Green,
2003). In vitro, Tax-1 exhibits interactions with various proteins of
the CREB/ATF family transcription factors, such as CREB, CREM,
ATF1-ATF4, XBP1 (Franklin et al., 1993; Low et al., 1994; Bantig-
nies et al., 1996; Winter et al., 2007; Boxus et al., 2008). Tax-2
proteins are also able to activate the CREB/ATF pathways, and can
form a Tax-2-CREB/ATF-TxRE ternary complex in vitro by inter-
acting with the b-Zip domain of CREB/ATF factors (Ross et al.,
1997). The functional regions or domains important for transac-
tivation through the CREB/ATF signaling pathway are similar, but
not identical, in Tax-1 and Tax-2 (Ross et al., 1997). Due to the
similarities in sequences of Tax-1 and Tax-3, Tax-3 also exhibits
interactions with proteins from the CREB/ATF family made pos-
sible, through the presence of putative KID-like domain in Tax-3,
which is critical for binding to CBP/p300 (Calattini et al., 2006;
Chevalier et al., 2006).
Studies comparing the relative transactivation functions of Tax-
1 and Tax-2 indicate significant differences as well as similarities in
transactivation activities via NF-κB pathways between the Tax-1
and Tax-2 proteins (Sheehy et al., 2006). Both Tax-1 and Tax-2
activate the canonical NF-κB pathway through interacting with
multiple NF-κB regulators. Although, the complete scheme of
canonical NF-κB activation by Tax-1 and Tax-2 has not been fully
elucidated yet, the activation of the IKK complex by Tax-1 and
Tax-2 through binding with its scaffold subunit IKKγ (NEMO) is
considered as a central event (Meertens et al., 2004b; Higuchi and
Fujii, 2009). In addition to the canonical NF-κB pathway, Tax-1
activates the non-canonical NF-κB pathway (Xiao et al., 2001).
Tax-1 binds to the IKK complex and NF-κB2/p100, resulting in
IKKα mediated p100 phosphorylation and subsequent p100 pro-
cessing into p52 (Xiao et al., 2001). Interestingly, Tax-2 cannot
induce p100 processing into p52 when transiently expressed in the
Jurkat T-cell line, although Tax-2 can activate the canonical NF-κB
pathway to a level comparable to Tax-1 (Higuchi et al., 2007). The
major defect of Tax-2 in p100 processing can be attributed to its
inability to interact with p100 (Higuchi et al., 2007). Moreover,
Tax-2 interaction with proteins such as IKKγ may account for
its ability to increase transcription via the NF-κB pathway (Lewis
et al., 2002).
TAX-2 FUNCTIONS TO INHIBIT CELLULAR p53
A primary function of HTLV-1 Tax-1 is to inactivate the cellu-
lar p53 tumor suppressor in order to establish immortalization
and transformation of T-cells. Consequently, high levels of cellu-
lar inactive, wild type p53 is found in Tax-transfected, HTLV-1 cell
lines, as well as primary cells isolated from ATL patients. Interest-
ingly, in HTLV-2 infected cells (both subtypes A and B), high levels
of transcriptionally inhibited p53 are identified (Mahieux et al.,
2000a,b). Tax-2A appears to inhibit p53 function less efficiently as
compared to Tax-1 or Tax-2B (Mahieux et al., 2000a,b). Mechanis-
tically, the inhibition of p53 by Tax-2 occurs through the activation
of the NF-κB pathway, similar to Tax-1. This also imparts a lack
of correlation to p53 inhibition by Tax-2 to CREB/ATF activation.
Tax-2 also uniquely interacts with CBP, but not p300 in order to
repress p53 (Meertens et al., 2004b).
TAX-1, BUT NOT TAX-2 IS A POTENT INDUCED OF MICRONUCLEI
FORMATION
Distinct phenotypic differences are observed in Tax-1 and Tax-
2 expressing cells in vitro. This could explain why HTLV-2 is
not associated with leukemic disease. Tax-2 has a lower trans-
activation activity of the HTVL-2 LTR, indicating a decrease in
viral gene expression as well as a suppression of cellular Tax-2-
responsive genes (Feuer and Green, 2005). Correlating with the
enhanced transactivation effect of Tax-1, Tax-1 expressing cells
induce micronuclei formation, which is a marker for genomic
instability (Semmes et al., 1996; Xie et al., 2006). To date, Tax-2
has been shown to lack micronuclei inductive ability, which seems
to correlate with a loss of the carboxy-termini as compared to
Tax-1.
TAX-1, TAX-2, AND TAX-3 EXHIBIT DIFFERENT PATTERNS OF
LOCALIZATION
Tax-1 has been described to shuttle between the nucleus and
cytoplasm being predominantly localized in the nucleus, where
it is been shown to form speckled structures (Semmes and Jeang,
1996). However, Tax-2 is localized predominantly in the cytoplasm
of the HTLV-2-immortalized or transformed T-cells due to the
presence of a 10 amino acid domain (amino acids 90–100) unique
to Tax-2 (Meertens et al., 2004a; Chevalier et al., 2005). Further-
more, by transiently transfecting HeLa cells with GFP-Tax-3Pyl43
(a full-length provirus), Calattini et al. (2006) showed that Tax-3
has a strong nuclear localization that is similar to that of Tax-1 and
simian Tax-3 but different from that of Tax-2. Nevertheless, some
cytoplasmic speckles are also detectable in Tax-3Pyl43-expressing
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cells (Calattini et al., 2006). A combination of the NLS and the
NES contained within Tax-1, as well as the susceptibility of the
protein to PTMs such as sumoylation and ubiquitination results
in the shuttling and retention of Tax-1 in the nucleus and/or
the cytoplasm. Indeed, Tax-2 has been shown to be modified by
ubiquitination and sumoylation in vitro (Turci et al., 2009). Addi-
tionally, this Tax-2 was shown to be localized in the nucleus with
RelA, indicating homologous in vitro function of Tax-1 (Turci
et al., 2009).
T-CELL IMMORTALIZATION OF TAX-1 VERSUS TAX-2
Due to the fact that HTLV-2 does not cause leukemia as HTLV-
1 does, it is important to determine the mechanism of T-cell
immortalization of Tax-1 as compared to Tax-2. In one recent
study, Tax-2 has been shown to immortalize human CD4+T-
cell at a higher activity than those transduced with Tax-1 (Imai
et al., 2012). These distinct differences in T-cell immortalization
may play a role in the drastically different pathogenesis associated
with these two viruses. Another recent study has demonstrated
the oncogenic properties of Tax-2 in the context of CD4+T-cell
immortalization. Ren et al. (2012) immortalized CD4+T-cells
to a CD3/TCRαβ/CD4/CD25/CD45RO/CD69 phenotype using
Tax-2, therefore generating a distinct T-cell line. These cells consti-
tutively activated PI3K/Akt, IκB/NF-κB, MAPK, and STAT3 (Ren
et al., 2012).
CHARACTERIZATION OF HTLV-3 TAX-3
As the most recently discovered HTLV virus, there is a great need to
characterize the pathogenicity of HTLV-3 as compared to HTLV-
1. To date, no pathogenicity has been associated with HTLV-3, a
virus which only has approximately 60% homology to HTLV-1.
Early data indicates that Tax-3 displays strong similarities to Tax-1
in terms of sequence homology and motifs (Calattini et al., 2006).
Tax-3 is able to activate transcription in vitro from the LTRs of
HTLV-1, -2, and -3 as well as activates some cellular genes through
the activation of the NF-κB pathway and inhibits transcriptional
activity of cellular p53 (Calattini et al., 2006). A very recent study
by Chevalier et al. (2012) utilized a DNA microarray to determine
the global gene expression profile of different cell lines express-
ing Tax-1, Tax-2, or Tax-3. From this analysis, 48 common genes
were found differentially regulated by all HTLV-1 transactivators
screened, indicating that dysregulation of these genes are charac-
teristic to all HTLV-1 infections. Additionally, this group identified
70 genes which are specifically upregulated by Tax-1 and Tax-3,
indicating that these two viral proteins are closely related in terms
of dysregulation of cellular genes. In contrast, Tax-1 and Tax-2 had
only one gene in common as Tax-2 and Tax-3 only had eight genes
in common (Chevalier et al., 2012). Functionally, the genes upreg-
ulated by both Tax-1 and Tax-3 are involved with regulation of
transcription, apoptosis, NF-κB, immunity, proliferation, and dif-
ferentiation. This is the first study to show that Tax-3 is a functional
analog of Tax-1, suggesting a similar associated pathogenesis.
CONCLUSION
The past 35 years have yielded a significant amount of meaningful
data, not only in regard to HTLV-1, but in regard to the Tax onco-
protein itself. In this review, the role of Tax in major cellular events
such as transcription, cell cycle, and DNA damage have been dis-
cussed. PTMs and subcellular localization have been shown to have
both an effect on Tax as well as being affected by Tax. Numerous
interactions have been highlighted which illustrate the oncogenic
potential of this transactivator protein. Yet, it remains clear that,
while well studied, the mechanisms of Tax as they relate to onco-
genesis are still incompletely understood. While the labyrinth of
interactions between Tax and host cellular proteins remains com-
plex and inadequately illuminated, one simple fact is made starkly
apparent: tax does not act alone.
This deceptively simple concept has driven, and should con-
tinue to drive, current and future research into this oncoprotein.
Research into the interactions between Tax and other viral proteins
(such as HBZ), interplay between Tax and miRNA during cellular
transformation, and modulation of intricate cellular complexes
(such as CBP/p300 and SWI/SNF) by Tax all provide promising
avenues for further understanding of Tax-mediated cellular trans-
formation requirements and, consequently, possible therapeutic
targets. In fact, the promiscuity of Tax provides both great strength
and weakness to the effectiveness of therapeutically targeting the
oncoprotein in that direct targeting of Tax has a radiating effect
on the major cellular pathways. It is important to note, however,
that without a detailed understanding of the various branches of
the Tax interactome, there exists the strong possibility of uncon-
trolled off-target effects. With improved understanding and more
focused therapeutic approaches, modulating cellular Tax could
have broad implications for the host cell and, consequently, be
a first step in effective clinical treatments of HTLV-1 disease
states.
Thanks to the excellent work of numerous talented researchers
in the field, understanding the comprehensive role of Tax in
HTLV-1 infections continues to be an evolving process. Many
of the discoveries mentioned earlier in this review will provide
promising avenues of future investigation. For example, a grow-
ing understanding of miRNA machinery has created another level
of complexity in better defining cellular and viral protein reg-
ulation. Further research into the interactions between Tax and
cellular miRNA (and possibly its machinery) and the result-
ing effect on oncogenesis will be required (Bellon et al., 2010;
Jeang, 2010). This area of research naturally leads into inves-
tigations of the interactions between Tax and cellular miRNA
and components such as Drosha and Dicer (Rahman et al.,
2012). The study of this interaction may shed light on a num-
ber of the mechanisms of Tax as they relate to protein regula-
tion and cell cycle. Moreover, the further development of ani-
mal models including rat, rabbit, and humanized mouse mod-
els will prove critical in advancing the understanding of the
mechanisms of Tax in vivo. The development of such models
would also advance the study of possible therapeutic targets for
both viral and cellular genes unique to infected cells. Finally,
more fundamental concepts will require further study, includ-
ing the development of a crystal structure for Tax and further
study into histone degradation versus mRNA downregulation
as seen in Tax expressing cells. Cumulatively, much has been
learned about Tax over the past 35 years, but there remains much
more to discover before this fascinating oncoprotein can be fully
understood.
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